Amedisys Faces Lawsuit Over Lender Control of Board

Amedisys Inc. (NASDAQ: AMED) has been accused of entering into illegal credit agreements with lenders, granting them influence in changes within Amedisys’ administration, according to a class action lawsuit filed against the major home health and hospice provider. The lawsuit claims Amedisys’ board established an illegal agreement in 2012 with JP Morgan Chase Bank and […]

Amedisys Agrees to $150 Settlement to Resolve False Billing Allegations

Home health giant Amedisys Inc. (NASDAQ: AMED) has agreed to a $150 million settlement with the federal government for allegations that the company submitted false home healthcare billings to Medicare.  The national provider of home health care services allegedly improperly billed Medicare for ineligible patients and services including billing for services that were not medically […]

Amedisys to Close, Consolidate 54 Home Care Locations

National home care provider Amedisys, Inc. (Nasdaq: AMED) says it will close and consolidate a total of 54 locations across the country.  The locations consist of 23 home health and six hospice branches that will close, while consolidating 25 other home health and hospice care centers nationwide. As a result of these actions, Amedisys expects […]

Amedisys Performance Falters, Execs to Push for Turnaround

Nationwide home care and hospice provider Amedisys (NASDAQ: AMED) said the company is focused on transformation following the announcement of missed earnings Wednesday and a net loss from continuing operations in the fourth quarter of 2013. The company cited increasing health care costs for employees as an unforeseen drag on company performance as well as […]

Home Health Drug Intervention Cuts Hospital Visits by 8%

Home health intervention with medication management can reduce hospital readmissions by as much as 8%, according to a joint study from national home health care provider Amedisys and Purdue University. The study, conducted from January 2012 through April 2012, reveals that a patient population utilizing medication intervention post-discharge had a 4% hospital admission rate, compared […]

Home Health Named Best Partner in Reducing Hospital Readmissions

Partnering with home health care agencies is emerging as a new model of care and a core strategy in preventing hospital readmissions, according to a new survey. Home health partnerships were the number-one strategy that 73% of senior hospital leaders adopt to lower preventable readmissions, as noted in a survey conducted by HealthLeaders Media Intelligence […]

Amedisys Reports 2Q Earnings Slump

Home health care and hospice provider Amedisys (NASDAQ: AMED) today announced adjusted earnings from continuing operations down 38% in the second quarter to $5.4 million or $0.17 per diluted share. The adjusted results reflect the addition of exit activity costs, the gain on sale of care centers and legal fees associated with investigations, the company […]

Home Health Companies Fall Out of Wall Street Favor Following CMS Proposal

Publicly held home health companies faltered on Wall Street in response to an announcement last week from the Centers for Medicare and Medicaid Services proposing Medicare reimbursements to home health providers will fall 1.5% in 2014, or $290 million based on estimates. Public companies including Gentiva Health Services (NASDAQ: GTIV) and Amedisys Inc. (NASDAQ: AMED) […]

Amedisys Prepares to Divest 35 Home Health Care Centers

Amedisys Inc. (NASDAQ: AMED) announced Friday it has retained a mergers and acquisitions company to help divest dozens of care centers in the coming months.  A nationwide health care at home company that currently covers 380,000 patients, Amedisys announced in its first quarter earnings statement it was planning to divest 50 of its care properties, […]